- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07661004
Evaluation of the Efficacy and Tolerability of the LED Mask With or Without the Serum Formula on the Signs of Facial Photodamage .
Evaluation of the Efficacy and Tolerability of the LED Mask With or Without the Serum Formula on the Signs of Facial Photodamage
Main objective : To evaluate the anti-aging effectiveness of the LED mask alone on at least one studied anti-aging parameters (including some targeted wrinkles) after 3 months versus baseline
Secondary objectives:
- Anti-aging clinical score (radiance, skin tone, fine line, ptose, plumpness, ..)
- Evaluate the consumer perception (self-evaluation)
- Tolerance
- Standardized pictures (all light) and pictures analysis
- Comparison of effectiveness between the 2 groups (with and without formula
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Rational Photodamaged/aged facial skin is characterized by thinner and drier skin, with increasing sags and wrinkles due to the loss of collagen and elastic tissue. Aging skin is also much more susceptible to the development of brown spots and pigmentation.
The use of LED masks to combat skin aging is based on a scientific principle called photobiomodulation. Red and near-infrared light stimulates cellular repair mechanisms without heating or damaging tissues. Its safety profile is well-documented across all skin types and side effects of phototherapy have been shown as being minimal and temporary.
Design:
Prospective, monocentric, open, non-randomized study conducted in healthy female participant aged 35 to 60 years.
The clinical investigation is design to evaluate the efficacy and tolerability of a LED mask with or without a serum formula on the anti-aging signs of the face.
There are 2 different groups:
Group 1: investigational device alone /Group 2: investigational device + cosmetic serum. Inclusion in each group will not be randomized but will be sequential: group 1 first and then group 2.
the evaluation times are : baseline, Timmedialy, after 7 days (D7), after one month (T1M), after 2 months (T2M), after 3 months (3M) Reglementation The clinical investigation will be conducted in compliance with Good Clinical Practice (GCP) guidelines and applicable regulatory requierement for medical device investigation, ISO 14155 Statistic Safety analyses will be performed on the SS population, while efficacy analyses will be primary performed on the ITT population. If the sample size between the PP and ITT differs by more than 10%, the efficacy analysis will also be performed on the PP population.
Evaluations criterias Clinical Grading of Efficacy Parameters Assessed with scale 10 grade -point scale (0-9) or atlas photonumeric for the items : Fine lines, Roughness , Skin tone evenness, Radiance , Plumpness, Firmness, Suppleness, Elasticity, Forehead wrinkles, Glabella wrinkles, Crow's feet wrinkles, Wrinkles on the corner of lips, Ptosis on the lower face , Nasolabial fold.
The significant change versus baseline for each item will be evaluated at each time point.
The self assessment efficacy questionnaire:
The answers to the efficacy questionnaire will be summarized in the frequency table by category , together with 100% stacked bar charts.
Safety Assessment AEs will be listed by participant including time of onset, time from the first administration of clinical investigation drug, duration, intensity, action taken, corrective therapies, outcomes, relationship to clinical investigation drug and serousness.
Th dermatologist will assess the overall tolerance on a 4-grade (Very good (1); Good (2); Moderate (3); Bad (4)) at each visits.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Audrey Natalizio, Clinical Project Manager
- Telefonnummer: + 33(0) 472 82 36 56
- E-Mail: Audrey.Natalizio@cpt.eurofinseu.com
Studienorte
-
-
New Jersey
-
Piscataway, New Jersey, Vereinigte Staaten, 08854
- Eurofins CRL
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Female subjects aged between 35-60y.o
- Presenting all skin types
- Presenting all phototype according to Fitzpatrick Classification
- Sensitive skin (50%) - declarative
- Daily user of SPF30 or 50+ for at least 30 days
- User or not of LED masks (collected data)
- Mask adapted to the shape of the face
- Having mild to moderate scores (as indicated) for the items parameters
- Subjects willing not to change their face/eyes make-up removal products and habits, and shower habits (e.g. shampoo, shower gel), and make-up products (eyes and mouth) throughout the course of the study.
- Subjects willing to use the investigational devices and/or products on the face throughout the course of the study period
- Subjects taking an effective oral contraception or other methods of contraception for the duration of the study
- Written Informed Consent Form to participate in the study
- illingness and ability to comply with protocol requirements
Exclusion Criteria:
- Subjects having allergy or sensitivity to LED Light
- Subjects having at risk of epilepsy
- subject who may have headaches
- Subjects having participated in the clinical study using anti-aging formula on the face within at least 3 months preceding the baseline visit
- Subjects having used any cosmetic products with exfoliating or astringing allegation on the face within at least 4 weeks preceding the baseline visit
- Subject with arterial circulatory disorders in the treated area,
- Subjects with sensitivity troubles and pain perception impairment, facial paralysis,
- Subjects with degenerative and vascular retinal disease,
- Subjects with known problems of scarring or wound healing,
- History of photosensitivity or photo allergy
- History of chronic viral infections (herpes simplex, ZONA…) and last outbreak within 12 months preceding the baseline visit
- Subject having an underlying dermatological disease or conditions on the face, which in the investigator's opinion, could interfere with study evaluation
- Subjects with a melanoma history in the family (parents or grandparents)
- Subjects undergone the radiotherapy in the treated areas,
- Subject having excessive moles, excessive pigmented spots, tattoos, scars, irritated skin, etc. at the test area that could influence the investigation
- Subject with a history of surgery to the treatment concerned areas within 6 months preceding the baseline visit
- Subject reports (or plans to) sunbath or overexpose to UV-light (mountains sports, phototherapy, tanning salon use…) for aesthetic or therapeutic reason one month before the study start (or during the study).
- Subject having modified their cosmetic habits (moisturizing skin care, cleansers, make-up removers, make-up, shower products, shampoo…) during the 2 weeks before baseline visit.
Subject uses or has used any of the medications or topical treatments/skincare products/procedure below without relevant wash-out period before the baseline visit (or is unwilling or unable to accept to follow the wash-out period below during the study)
-
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Nicht randomisiert
- Interventionsmodell: Sequenzielle Zuweisung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: ARM 1 : MASK LED ALONE
Participant aged between 40 and 55 years who presents signs of photodamage on the face as well as anti-aging signs (wrinkles, complexion, luminosity)
|
Application of mask LED on the face, 5 times a week for 10 minutes for 3 months.
The participant will apply his usual moisturizer and sunscreen
|
|
Aktiver Komparator: ARM2 : DEVICE + COSMETIC FORMULA
Participant aged between 40 and 55 years who presents signs of photodamage on the face as well as anti-aging signs (wrinkles, complexion, luminosity)
|
application of the LED mask 5 times a week during 10 minutes and the cosmetic formula twice a day for 3 months Paticipant will apply his usual moisturizer and sunscreen
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Improvement of anti-aging parameters
Zeitfenster: baseline to 3 months
|
The expert clinical grading will perform a standartied clinical evaluation oth the 14 anti-aging items with the scale 10 grade -point scale (0-9) or L'Oréal Skin Aging Atlas (scale photonumeric)
|
baseline to 3 months
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Global tolerance
Zeitfenster: Immediate time to 3 months
|
The investigator will assign an overall tolerance score at each visit using the following scale 1: very good ; 2: good ; 3: Moderate ; 4 : Bad
|
Immediate time to 3 months
|
|
Self assessment questionnaire
Zeitfenster: immediat time to 3 months
|
Participant will complete a subjective evaluation questionnaire to capture their perception of treatment outcomes.
The questionnaire, using a 5 point scale (1= Disagree to 5= Agree), will include items on visible results (confort, ease of use, improvement in overall skin appereance, satisfaction)
|
immediat time to 3 months
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- EV 2512-1248 MASK LED
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Antialterung
-
Seoul National University HospitalAbgeschlossenAltern | Photo-AgingKorea, Republik von
-
Seoul National University HospitalAbgeschlossen
-
University of MichiganBausch Health Americas, Inc.Abgeschlossen
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinAbgeschlossenAnti-IntegrenFrankreich
-
Clinique OvoBeendet
-
ART Fertility Clinics LLCAbgeschlossenAnti-Müller-HormonresistenzVereinigte Arabische Emirate
-
Cardiovascular Academy Society, TurkeyAbgeschlossen
-
Beckman Coulter, Inc.Abgeschlossen
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceRekrutierungAnti-MAG-NeuropathieFrankreich
-
Centre Hospitalier Universitaire de NīmesAbgeschlossenPädiatrische Population | Anti-InfektivumFrankreich
Klinische Studien zur MASK LED
-
Universidade Estadual de LondrinaAbgeschlossenPhototherapieBrasilien
-
Pathway Medtech, LLC.Haku TechnologyRekrutierungSchlafapnoe | Schlafqualität | Schlafstörungen (SDB)Belgien
-
VA Office of Research and DevelopmentAbgeschlossenSchädel-Hirn-Trauma | Posttraumatische BelastungsstörungVereinigte Staaten
-
University of Nove de JulhoUnbekanntTemporomandibuläre StörungBrasilien
-
Federal University of Health Science of Porto AlegreAbgeschlossen
-
Siperstein DermatologyAbgeschlossen
-
Cairo UniversityNoch keine Rekrutierung
-
University of Medicine and Pharmacy at Ho Chi Minh...AbgeschlossenSchmerztherapie | Wurzelresorption | Zahnbewegung | KieferorthopädieVietnam
-
New York Institute of TechnologyRekrutierungSchmerz, chronisch | Ehlers-Danlos-SyndromVereinigte Staaten
-
Universidade Norte do ParanáUniversidade Estadual de MaringáAbgeschlossenSchmerzen im unteren Rücken | Hydrotherapie | Anstrengung; ÜberschussBrasilien